Shire to announce third quarter 2014 results

Shire to announce third quarter 2014 results Dublin, Ireland - October 21, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) willannounce third quarter 2014 earnings on Friday October 24, 2014. Results press release will be 07:00 EDT / 12:00 BSTissued at: Investor conference call time: 09:00 EDT / 14:00 BST Live conference call for investors: Flemming Ornskov, Chief Executive Officer and James Bowling, Interim ChiefFinancial Officer will host the investor and analyst conference call at 9:00EDT / 14:00 BST. The details of the conference call are as follows: UK dial in: 0808 237 0030 or 020 3139 4830 US dial in: 1 866 928 7517 or 1 718 873 9077 International Access Numbers: http://wpc.1726.planetstream.net/001726/FEL_Events_International_Access_List.pdf Password/Conf ID: 40489933# Live Webcast: http://event.onlineseminarsolutions.com/r.htm?e=819579&s=1&k=49B3FECE7F0EC468D8286E2146662748 Replay: A replay of the presentation will be available for two weeks by phone and bywebcast for three months. Details can be found on our Investor Relationswebsite: http://www.shire.com/shireplc/en/investors . For further information please contact: Investor RelationsJeff Poulton [email protected] +1 781 482 0945Sarah Elton-Farr [email protected] +44 1256 894157 MediaStephanie Fagan [email protected] +1 201 572 9581 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We focus on providing treatments in Neuroscience, Rare Diseases,Gastrointestinal, and Internal Medicine and we are developing treatments forsymptomatic conditions treated by specialist physicians in other targetedtherapeutic areas, such as Ophthalmology. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com